HIV antiretroviral drugs, dolutegravir, maraviroc and ritonavir-boosted atazanavir use different pathways to affect inflammation, senescence and insulin sensitivity in human coronary endothelial cells

• Martine Auclair,

  Roles Investigation

  Affiliations Sorbonne Université, Paris, France, Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France, ICAN, Institute of Cardiometabolism and Nutrition, Paris, France

  ⨯
• Anne-Claire Guénantin,

  Roles Formal analysis, Investigation, Validation

  Affiliations Sorbonne Université, Paris, France, Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France, ICAN, Institute of Cardiometabolism and Nutrition, Paris, France

  ⨯
• Soraya Fellahi,

  Roles Investigation

  Affiliations Sorbonne Université, Paris, France, Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France, ICAN, Institute of Cardiometabolism and Nutrition, Paris, France, Department of Biochemistry, Tenon Hospital, APHP, Paris, France

  ⨯
• Marie Garcia,

  Roles Investigation

  Affiliations Sorbonne Université, Paris, France, Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France, ICAN, Institute of Cardiometabolism and Nutrition, Paris, France

  ⨯
• Jacqueline Capeau

  Roles Conceptualization, Formal analysis, Funding acquisition, Supervision, Validation, Writing – original draft

  * E-mail: jacqueline.capeau@inserm.fr

  Affiliations Sorbonne Université, Paris, France, Inserm UMR_S938, Centre de Recherche Saint-Antoine, Paris, France, ICAN, Institute of Cardiometabolism and Nutrition, Paris, France

  http://orcid.org/0000-0002-1710-4186

  ⨯